Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/38832
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorAmariles Muñoz, Pedro-
dc.contributor.authorCeballos Rueda, Javier Mauricio-
dc.contributor.authorGranados Vega, Elkyn Johan-
dc.contributor.authorMontoya Guarín, Carlos Julio-
dc.date.accessioned2024-03-27T20:31:19Z-
dc.date.available2024-03-27T20:31:19Z-
dc.date.issued2021-
dc.identifier.citationAmariles P, Granados J, Ceballos M, Montoya CJ. COVID-19 in Colombia endpoints. Are we different, like Europe? Res Social Adm Pharm. 2021 Jan;17(1):2036-2039. doi: 10.1016/j.sapharm.2020.03.013.spa
dc.identifier.issn1551-7411-
dc.identifier.urihttps://hdl.handle.net/10495/38832-
dc.description.abstractABSTRACT: The infection by the new coronavirus (SARS-CoV-2) has taken the dimension of a pandemic, affecting more than 160 countries in a few weeks. In Colombia, despite the implementation of the rules established by the national government, exists an elevate concern both for mortality and for the limited capacity of the health system to respond effectively to the needs of patients infected. For Colombia, assuming a case fatality rate among people infected with SARS-CoV-2 of 0.6% (average data from the information reported for Latin American countries for March 18) (Table 1), the number of deaths, in one or two weeks, could be 16 and 243, respectively. These estimates differ markedly from those documented in countries such as Spain and Italy, in which COVID-19 case fatality rates exceed 8% (case of Italy) and from the percentage of patients who have required intensive care, which has ranged from 9% to 11% of patients in Mediterranean European countries. These differences could be explained due to: a) the percentage of the population at risk (individuals older than 60 years); b) a higher epidemiological exposure to viral respiratory infections associated with more frequent exposure to them, due to geographic and climatic conditions; c) less spread of the virus by location in the tropical zone; and d) earlier preventive measures to contain the spread of SARS-CoV-2 infection. Therefore, it is possible to establish that the situation in this country will be different from in European Mediterranean and that Colombia could have different endpoints from Spain and Italy.spa
dc.format.extent4 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherElsevierspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleCOVID-19 in Colombia endpoints. Are we different, like Europe?spa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Investigación de Tecnología en Regencia de Farmaciaspa
dc.publisher.groupPromoción y Prevención Farmacéuticaspa
dc.identifier.doi10.1016/j.sapharm.2020.03.013-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1934-8150-
oaire.citationtitleResearch in Social and Administrative Pharmacyspa
oaire.citationstartpage2036spa
oaire.citationendpage2039spa
oaire.citationvolume17spa
oaire.citationissue1spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.publisher.placeNueva York, Estados Unidosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsCOVID-19-
dc.subject.decsColombia - epidemiología-
dc.subject.decsColombia - epidemiology-
dc.subject.decsAtención a la Salud - organización & administración-
dc.subject.decsDelivery of Health Care - organization & administration-
dc.subject.decsEuropa (Continente) - epidemiología-
dc.subject.decsEurope - epidemiology-
dc.subject.decsHumanos-
dc.subject.decsHumans-
dc.subject.decsFactores de Riesgo-
dc.subject.decsRisk Factors-
dc.description.researchgroupidCOL0135121spa
dc.description.researchgroupidCOL0074661spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000086382-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D003105-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D003695-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D005060-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D006801-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D012307-
dc.relation.ispartofjournalabbrevRes. Social Adm. Pharm.spa
Aparece en las colecciones: Artículos de Revista en Farmacéutica y Alimentarias

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
AmarilesPedro_2021_COVID-19_Colombia_Endpoints.pdfArtículo de investigación1.88 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons